United States Últimas notícias

Carnival Corporation (NYSE:CCL) reported third-quarter 2026 financial results, with record revenue and stronger operating expectations for the full year.

Propanc Biopharma (NASDAQ:PPCB) reported fiscal 2026 financial results and provided an update on development plans for PRP, its investigational cancer therapy candidate.

Dan Ives, partner and senior managing director at Yorkville Ives & Co., talks about why President Donald Trump is gathering tech leaders like Mark Zuckerberg and Nvidia's Jensen Huang at the White House. He also talks about the expected IPO of Anthropic and the debate over how to regulate artificial intelligence. He says too much regulation could give China an advantage. He speaks on "Bloomberg Surveillance."

Lite Strategy (NASDAQ:LITS) reported fiscal 2026 results for the year ended June 30, marking its first fiscal year operating under a Litecoin treasury strategy.

1-800-FLOWERS.COM (NASDAQ:FLWS) announced a definitive agreement to sell PersonalizationMall.com and Things Remembered to PlanetArt, LLC for approximately $45 million in cash.

Iovance Biotherapeutics (NASDAQ:IOVA) raised its full-year 2026 revenue guidance following stronger-than-expected demand for its commercial products, Amtagvi and Proleukin.

Nurix Therapeutics (NASDAQ:NRIX) announced that it achieved a $7 million research milestone under its collaboration with Pfizer (NYSE:PFE) to develop degrader antibody conjugates.

BeyondSpring (NASDAQ:BYSI) announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to Plinabulin in combination with docetaxel for previously treated advanced non-squamous lung cancer.

BIO-key (NASDAQ:BKYI) announced a partnership with Al Majlis Group to introduce its identity security platform to organizations in the United Arab Emirates and Saudi Arabia.

Immix Biopharma (NASDAQ:IMMX) reported interim results from its Phase 2 NEXICART-2 clinical trial evaluating NXC-201 in patients with relapsed or refractory AL amyloidosis.

Turbo Energy (NASDAQ:TURB) reported first-half 2026 financial results, with significant revenue growth and a return to profitability.

Dan Ives, partner and senior managing director at Yorkville Ives & Co., examines Anthropic PBC as the company prepares to file its initial public offering and looks at the growing list of concerns surrounding AI.